SCHEMBL2556896

SCHEMBL2556896

COCCN1CC(c2ccc(OC(F)F)c3oc4ccncc4c23)CC1=O

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.49
PDE4B Q07343 3/20 0.44
PDE4D Q08499 2/20 0.44
PDE4A P27815 1/20 0.44
PDE4C Q08493 1/20 0.44
CYP3A4 P08684 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP17A1 P05093 1/20 0.31
CYP19A1 P11511 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
FPR1 P21462 1/20 0.31
FPR2 P25090 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2557534 0.94 PDE10A (0.47) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2560888 0.92 PDE10A (0.48) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2577646 0.92 PDE10A (0.47) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2560140 0.91 PDE10A (0.47) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2563217 0.91 PDE10A (0.49) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2576250 0.89 PDE10A (0.46) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2556888 0.88 PDE10A (0.48) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL7709576 0.88 PDE4B (0.46) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2563041 0.88 PDE10A (0.47) PDE10APDE4BPDE4DPDE4APDE4C
SCHEMBL2561373 0.88 PDE4A (0.47) PDE10APDE4BPDE4DPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO claimed
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed